Videos
Understanding the Phenomenology and Impact of Psychosis in Parkinson Disease: William Ondo, MD
June 30th 2025The director of the Movement Disorders Clinic at Houston Methodist Hospital discussed the distinct features, progression, and clinical implications of psychosis in Parkinson disease. [WATCH TIME: 4 minutes]
Incorporating Palliative Care Principles into Movement Disorder Management: Jennifer Corcoran, MD
June 30th 2025The movement disorder neurologist at University of Rochester Medical Center outlined a 5-pillar model that emphasized holistic care, patient-centered communication, and proactive support in movement disorders. [WATCH TIME: 5 minutes]
Improving the Management of Parkinson Through Psychological Interventions: Marcia Pasqualini, PhD
June 30th 2025The professor of psychology at Avila University discussed how cognitive behavioral therapy and social support can help to improve quality of life for individuals with Parkinson disease. [WATCH TIME: 4 minutes]
Common Challenges in Chronic Insomnia Management
June 27th 2025A panelist discusses how managing chronic insomnia requires setting realistic patient expectations around gradual improvement, emphasizing consistent effort over time, and using both clinical tools and patient feedback to assess progress toward more restorative sleep.
Patient and Clinician Perspectives on Empathy in Parkinson Disease Care: Daniel Irizarry, MD
June 27th 2025The medical advisor at Tactical Medical Solutions shared insights from both clinical and personal perspectives on the importance of empathy and active listening in managing Parkinson disease. [WATCH TIME: 3 minutes]
Balancing MS Relapse Risk With Personalized Therapy Decisions: Gabrielle Macaron, MD
June 26th 2025The assistant professor in the Department of Neuroscience at Université de Montréal discussed the importance of weighing the risks of multiple sclerosis against treatment risks, emphasizing individualized care. [WATCH TIME: 4 minutes]
Considering New Duchenne Muscular Dystrophy Therapies: Excon Skipping and Gene Therapy
June 25th 2025A panelist discusses how older DMD patients might benefit from newer genetic therapies including gene therapy and exon skipping, though eligibility depends on specific mutations and absence of pre-existing immunity to AAV vectors.
Case 2 Overview: Patient at 16 with Duchenne Muscular Dystrophy
June 25th 2025A panelist discusses how a 16-year-old DMD patient shows more rapid disease progression despite early steroid treatment, with early onset cardiac issues, scoliosis, and increasing upper limb weakness requiring comprehensive specialist care.
Understanding ALKS 2680’s Wake-Promoting Effects Through qEEG: Julia Chapman, PhD
June 24th 2025The postdoctoral researcher at the Woolcock Institute of Medical Research highlighted EEG-based evidence supporting ALKS 2680's wake-promoting effects in patients with narcolepsy and idiopathic hypersomnia. [WATCH TIME: 3 minutes]
Patients Voicing Key Needs for Migraine Care and Advocacy: Elizabeth W. Leroux, MD, FRCPC
June 24th 2025The neurologist and headache specialist at the Montreal Neurological Clinic spoke about a recent national survey presented at AHS 2025 that revealed insightful patient perspectives in migraine. [WATCH TIME: 5 minutes]
What Newly Approved STS101 Brings to Migraine Treatment Landscape: Stewart Tepper, MD
June 23rd 2025The professor of neurology at the Geisel School of Medicine at Dartmouth broke down the FDA approval of STS101, a new DHE nasal powder, and its implications for acute migraine care. [WATCH TIME: 7 minutes]
Clinicians Express Growing Optimism in ALS Research and Treatment Advancements
June 23rd 2025Experts in ALS care and research shared their optimism about emerging treatments, aiming to deepen scientific understanding, and the potential role of advocacy in accelerating progress. [WATCH TIME: 4 minutes]
Chronic Insomnia Diagnosis and Management
June 20th 2025A panelist discusses how managing chronic insomnia requires a comprehensive, multifaceted approach that integrates behavioral interventions like CBT-I with pharmacologic treatments, guided by thorough sleep assessments and tailored to each patient’s specific sleep patterns and comorbid conditions.
Promise and Challenges of Targeting PACAP to Treat Migraine: Michael Marmura, MD
June 19th 2025The director of outpatient care at Jefferson Headache Center weighed in on the future of PACAP as a migraine target and previewed upcoming innovations at the 2025 AHS Annual Meeting. [WATCH TIME: 3 minutes]
The Importance of Early Intervention in Duchenne Muscular Dystrophy
June 18th 2025A panelist discusses how comprehensive care for DMD patients involves early diagnosis, steroid treatment, consideration of mutation-specific therapies like exon skipping or gene therapy, and consistent monitoring by a multidisciplinary clinical team.
The Role of Gene Therapy for Patients with Duchenne Muscular Dystrophy
June 18th 2025A panelist discusses how gene therapy using microdystrophin delivered through AAV vectors shows promise for DMD treatment, though challenges remain with delivery efficiency and determining which patients will benefit most.
Exploring the Clinical Impact of Health and Wellness Coaching in MS Care: Cassandra Moore, MPH, CPH
June 18th 2025The associate vice president of strategy and innovation at the National MS Society highlighted the measurable benefits of health and wellness coaching for individuals with multiple sclerosis. [WATCH TIME: 5 minutes]
Bridging Sleep Science and Biomarkers in Neurodegeneration: Lea Grinberg, MD, PhD
June 17th 2025The neuropathologist at Mayo Clinic Florida discussed why EEG-based sleep biomarkers may help detect Alzheimer disease earlier and how they could enhance clinical trial design. [WATCH TIME: 3 minutes]
Using a Family-Centered Approach for Care in Pediatric Sleep Health: Funke Afolabi-Brown, MD, FAASM
June 17th 2025The chief executive officer of Restful Sleep MD emphasized the importance of tailoring pediatric sleep interventions to each family’s unique structure, values, and challenges. [WATCH TIME: 5 minutes]
Strengthening Duchenne Care Through Clinical Collaboration and Community Focus: Brenda L. Wong, MD
June 15th 2025The director of the DMD Program at UMass Chan Medical School shared her experience at the 2025 CureDuchenne FUTURES National Conference, held May 22-25, in San Antonio, Texas. [WATCH TIME: 5 minutes]
